p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Wild-type p53 (wt p53) gene transfer via adenovirus shows promise in cancer therapy by inducing apoptosis and radiosensitivity.
• Head and neck squamous cell carcinoma (SCC) often harbors p53 mutations, impacting treatment efficacy.

Purpose of the Study:

• To investigate the effects of adenoviral-mediated wt p53 gene transfer on cell cycle progression and radiosensitivity in a p53-mutated human head and neck squamous cell carcinoma cell line (SCC97).
• To explore the potential of combining p53 gene therapy with irradiation for enhanced anti-cancer effects.

Main Methods:

• Adenoviral-mediated transfer of the wt p53 gene into SCC97 cells.
• Cell cycle analysis (G1 and G2 arrest) following gene transfer and/or irradiation.
• Quantification of WAF1/p21, cyclin A2, and cyclin B1 expression levels.

Main Results:

• Ectopic expression of wt p53 in SCC97 cells led to a prolonged G1 arrest and increased WAF1/p21 expression.
• Irradiation alone caused a transient G2 arrest.
• Simultaneous wt p53 gene transfer and irradiation resulted in a permanent G2 arrest, decreased cyclin A2 and B1 levels, suggesting premature inactivation of the mitosis promoting factor.

Conclusions:

• Adenoviral-mediated wt p53 gene transfer in p53-mutated SCC97 cells increases WAF1/p21 expression and induces a permanent G2 arrest when combined with irradiation.
• This combination therapy potentially enhances radiosensitivity by disrupting the G2/M transition through p53-dependent mechanisms.